Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial
Publication
, Conference
Owens, E; Hotchkiss, KM; Norberg, P; Buckley, E; Ayasoufi, K; Threatt, S; Low, JT; Shoaf, ML; Goldston, M; Batich, K; Johnson, MO; Herndon, JE ...
Published in: Cancer Research
April 3, 2026
Duke Scholars
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 3, 2026
Volume
86
Issue
7_Supplement
Start / End Page
6477 / 6477
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology
Citation
APA
Chicago
ICMJE
MLA
NLM
Owens, E., Hotchkiss, K. M., Norberg, P., Buckley, E., Ayasoufi, K., Threatt, S., … Khasraw, M. (2026). Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. In Cancer Research (Vol. 86, pp. 6477–6477). American Association for Cancer Research (AACR). https://doi.org/10.1158/1538-7445.am2026-6477
Owens, Elizabeth, Kelly M. Hotchkiss, Pamela Norberg, Evan Buckley, Katayoun Ayasoufi, Stevie Threatt, Justin T. Low, et al. “Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial.” In Cancer Research, 86:6477–6477. American Association for Cancer Research (AACR), 2026. https://doi.org/10.1158/1538-7445.am2026-6477.
Owens E, Hotchkiss KM, Norberg P, Buckley E, Ayasoufi K, Threatt S, et al. Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. In: Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6477–6477.
Owens, Elizabeth, et al. “Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial.” Cancer Research, vol. 86, no. 7_Supplement, American Association for Cancer Research (AACR), 2026, pp. 6477–6477. Crossref, doi:10.1158/1538-7445.am2026-6477.
Owens E, Hotchkiss KM, Norberg P, Buckley E, Ayasoufi K, Threatt S, Low JT, Shoaf ML, Goldston M, Batich K, Johnson MO, Herndon JE, Nair SK, Weinhold K, Friedman HS, Ashley DM, Desjardins A, Sampson JH, Khasraw M. Abstract 6477: Peptide-based tumor-associated antigen vaccine in glioblastoma: Correlative results of the ETAPA Phase I clinical trial. Cancer Research. American Association for Cancer Research (AACR); 2026. p. 6477–6477.
Published In
Cancer Research
DOI
EISSN
1538-7445
ISSN
0008-5472
Publication Date
April 3, 2026
Volume
86
Issue
7_Supplement
Start / End Page
6477 / 6477
Publisher
American Association for Cancer Research (AACR)
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 3101 Biochemistry and cell biology